October 16, 2019
OrphanPacific, a joint venture between CRO CMIC Holdings and wholesaler Medipal Holdings, said on October 15 that it will take over the Japanese marketing authorization for Diazoxide Capsules 25 mg “MSD”, a treatment for hyperinsulinemic hypoglycemia, next month. The transfer...read more